Table 3 Adjusted Relationships of Leukocyte-related Parameters to the Prevalence of MUO.

Leukocyte, 10⁹/L

1.24 (1.12,1.38)

 < 0.01

1.24 (1.12,1.38)

 < 0.01

Q1(≤ 4.72)

Ref

Ref

Q2(4.73–5.42)

1.46 (1.00,2.14)

0.05

1.42 (0.97,2.09)

0.07

Q3(5.43–6.35)

1.89 (1.29,2.78)

 < 0.01

1.85 (1.25,2.73)

 < 0.01

Q4(> 6.35)

2.45 (1.66,3.63)

 < 0.01

2.48 (1.66,3.68)

 < 0.01

P for trend

 < 0.01

 < 0.01

Lymphocyte, 10⁹/L

1.26 (0.99,1.59)

0.06

1.25 (0.98,1.59)

0.08

Q1(≤ 1.37)

Ref

Ref

Q2(1.38–1.67)

1.44 (0.99,2.10)

0.06

1.44 (0.98,2.11)

0.06

Q3(1.68–2.06)

1.76 (1.20,2.57)

 < 0.01

1.83 (1.24,2.70)

 < 0.01

Q4(> 2.06)

2.01 (1.36,2.96)

 < 0.01

2.04 (1.38,3.03)

 < 0.01

P for trend

 < 0.01

 < 0.01

Monocyte, 10⁹/L

2.47 (0.78,7.79)

0.12

2.83 (0.90,8.89)

0.08

Q1(≤ 0.25)

Ref

Ref

Q2(0.26–0.31)

1.77 (1.22,2.59)

 < 0.01

1.72 (1.17,2.52)

 < 0.01

Q3(0.32–0.37)

1.51 (1.03,2.23)

 < 0.05

1.53 (1.04,2.26)

 < 0.05

Q4(> 0.37)

1.53 (1.04,2.25)

 < 0.05

1.56 (1.06,2.30)

 < 0.05

P for trend

0.06

 < 0.05

Neutrophil, 10⁹/L

1.28 (1.12,1.46)

 < 0.01

1.28 (1.12,1.47)

 < 0.01

Q1(≤ 2.63)

Ref

Ref

Q2(2.64–3.20)

1.45 (0.99,2.13)

0.06

1.41 (0.96,2.08)

0.08

Q3(3.21–3.87)

1.56 (1.07,2.29)

 < 0.05

1.51 (1.02,2.22)

 < 0.05

Q4(> 3.87)

2.21 (1.49,3.27)

 < 0.01

2.22 (1.49,3.30)

 < 0.05

P for trend

 < 0.01

 < 0.01

Eosinophil, 10⁹/L

6.16 (1.89,20.08)

 < 0.01

6.40 (1.94,21.17)

 < 0.01

Q1(≤ 0.07)

Ref

Ref

Q2(0.08–0.11)

1.70 (1.18,2.46)

 < 0.01

1.62 (1.12,2.35)

 < 0.05

Q3(0.12–0.18)

1.64 (1.13,2.40)

 < 0.05

1.64 (1.12,2.41)

 < 0.05

Q4(> 0.18)

1.98 (1.36,2.90)

 < 0.01

2.01 (1.37,2.96)

 < 0.01

P for trend

 < 0.01

 < 0.01

Basophil, 10⁶/L

1.01 (1.00,1.02)

 < 0.01

1.01 (1.00,1.02)

 < 0.01

Q1(≤ 20)

Ref

Ref

Q2(21–30)

1.21 (0.85,1.71)

0.29

1.17 (0.83,1.67)

0.37

Q3(31–40)

1.33 (0.91,1.96)

0.15

1.29 (0.87,1.91)

0.21

Q4(> 40)

1.58 (1.09,2.30)

 < 0.05

1.64 (1.12,2.40)

 < 0.05

P for trend

 < 0.05

 < 0.01